Edit Target: 63
Bempedoic acid> is a synthetic small‐molecule drug developed to lower low‐density lipoprotein cholesterol (LDL-C) by targeting lipid metabolism in the liver. Its design and development were based on a detailed understanding of cholesterol biosynthetic pathways rather than on a natural product scaffold.
Key Pathways:
-ATP Citrate Lyase (ACLY) Inhibition
-Fatty Acid Synthesis and Lipogenesis
• With reduced acetyl-CoA, de novo fatty acid synthesis is also curtailed.